Bioharvest Sciences Inc.2025财年第一财季实现净利润-2.34百万美元，同比增加64.44%

市场透视2025-05-24

5月24日，Bioharvest Sciences Inc.（BHST.US）公布财报，公告显示公司2025财年第一财季净利润为-2.34百万美元，同比增加64.44%；其中营业收入为7.86百万美元，同比增加47.19%，每股基本收益为-0.13美元。从资产负债表来看，Bioharvest Sciences Inc.（BHST.US）总负债27.47百万美元，其中短期债务10.04百万美元，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2537467153?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-24 00:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2537467153","market":"us","top_or_hot":-1,"title":"Bioharvest Sciences Inc.2025财年第一财季实现净利润-2.34百万美元，同比增加64.44%","media":"市场透视","content":"<div>\n<p>5月24日，Bioharvest Sciences Inc.（BHST.US）公布财报，公告显示公司2025财年第一财季净利润为-2.34百万美元，同比增加64.44%；其中营业收入为7.86百万美元，同比增加47.19%，每股基本收益为-0.13美元。从资产负债表来看，Bioharvest Sciences Inc.（BHST.US）总负债27.47百万美元，其中短期债务10.04百万美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000152a6ea7d52&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioharvest Sciences Inc.2025财年第一财季实现净利润-2.34百万美元，同比增加64.44%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioharvest Sciences Inc.2025财年第一财季实现净利润-2.34百万美元，同比增加64.44%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-24 00:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000152a6ea7d52&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月24日，Bioharvest Sciences Inc.（BHST.US）公布财报，公告显示公司2025财年第一财季净利润为-2.34百万美元，同比增加64.44%；其中营业收入为7.86百万美元，同比增加47.19%，每股基本收益为-0.13美元。从资产负债表来看，Bioharvest Sciences Inc.（BHST.US）总负债27.47百万美元，其中短期债务10.04百万美元，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000152a6ea7d52&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BHST","symbol_name":"BIOHARVEST SCIENCES INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000152a6ea7d52&s=b","article_id":"2537467153","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000152a6ea7d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2537467153","pubTimestamp":1748016066,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"5月24日，Bioharvest Sciences Inc.公布财报，公告显示公司2025财年第一财季净利润为-2.34百万美元，同比增加64.44%；其中营业收入为7.86百万美元，同比增加47.19%，每股基本收益为-0.13美元。从资产负债表来看，Bioharvest Sciences Inc.总负债27.47百万美元，其中短期债务10.04百万美元，资产负债比为0.97，流动比率为0.51。机构评级：截至2025年5月24日，当前有3家机构对Bioharvest Sciences Inc.目标价做出预测，其中目标均价为13.67美元，其中最低目标价为12.00美元，最高目标价为15.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"BHST":"BIOHARVEST SCIENCES INC"},"translate_title":"Bioharvest Sciences Inc. achieved net profit of-2.34 million US dollars in the first fiscal quarter of fiscal year 2025, a year-on-year increase of 64.44%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHST":0.9},"content_text":"5月24日，Bioharvest Sciences Inc.（BHST.US）公布财报，公告显示公司2025财年第一财季净利润为-2.34百万美元，同比增加64.44%；其中营业收入为7.86百万美元，同比增加47.19%，每股基本收益为-0.13美元。从资产负债表来看，Bioharvest Sciences Inc.（BHST.US）总负债27.47百万美元，其中短期债务10.04百万美元，资产负债比为0.97，流动比率为0.51。机构评级：截至2025年5月24日，当前有3家机构对Bioharvest Sciences Inc.目标价做出预测，其中目标均价为13.67美元，其中最低目标价为12.00美元，最高目标价为15.00美元。公司简介：BioHarvest Sciences Inc 是专利生物细胞生长平台种植技术的开发商和所有者。该公司拥有工业化大规模植物细胞生长技术，能够直接、持续地生产活性植物成分，而无需种植植物本身。该公司专注于利用其植物合成技术去开发下一代基于科学和临床的治疗解决方案，涉及两个垂直业务 - 营养保健和健康产品（如膳食补充剂）以及专注于特定医疗适应症的基于植物细胞的活性药物成分 (API)的开发。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2537467153","isCrawlerRequest":true}